LOXL2 and breast carcinoma: In tumor cells, LOXL2 can upregulate human epidermal growth factor receptor 2 (ErbB2) expression through the production of reactive oxygen species (ROS), and ErbB2-positive breast cancer patients with high LOXL2 expression have poorer OS and MFS [59].